Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22%2AMouth+Neoplasms%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22
/vufind/Search/Results?lookfor=%22%2AMouth+Neoplasms%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22
Search /vufind/Search2/Results?lookfor=%22%2AMouth+Neoplasms%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22
PubPharm (88)
1
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin : Phase I Trial With Expansion Cohort of DNA-PK Inhibition and IMRT in Cisplatin-Ineligible Patients With Stage 3-4 Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study : Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Participants With Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers - an immunoMATCH Pilot Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck : A Phase 2 Study of Ipatasertib in Combination With Pembrolizumab for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery : Wide-Field and High Resolution In Vivo Imaging of Oral Neoplasia Using Topical Fluorescent Dyes: A Feasibility Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery : Intraoperative Visualization of Oral Cavity Squamous Cell Carcinoma and High-Grade Dysplasia With Tozuleristide, a Fluorescent Tumor Marking Agent
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers : A Phase II/III Trial of Chemotherapy + Cetuximab vs Chemotherapy + Bevacizumab vs Atezolizumab + Bevacizumab Following Progression on Immune Checkpoint Inhibition in Recurrent/Metastatic Head and Neck Cancers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment : A Multi-Centre Prospective Community-Based Observational Study on Prediction of Malignant Progression of Clinically Suspicious Oral Lesions With STRATICYTE
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors : A Phase 2a, Double-blind, Placebo-controlled, Multi-center, Randomized Study Evaluating LSTA1 When Added to Standard of Care (SoC) Versus Standard of Care Alone in Subjects With Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors : A Phase 2a, Double-blind, Placebo-controlled, Multi-center, Randomized Study Evaluating LSTA1 When Added to Standard of Care (SoC) Versus Standard of Care Alone in Subjects With Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer : Phase I/Ib Study of AKT Inhibitor Ipatasertib With Chemoradiation for Locally Advanced Head and Neck Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
Nächster »
[9]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Recruiting
Medienart
88
Aufsätze
88
E-Artikel
88
E-Ressourcen
Zeitschriftentitel
86
ClinicalTrials.gov
2
WHO International Clinical Trials Registry Plat...
Thema
88
610
Recruitment Status: Recruiting
86
Mouth Neoplasms
66
Study Type: Interventional
37
Squamous Cell Carcinoma of Head and Neck
31
Carcinoma
30
Carcinoma, Squamous Cell
26
Laryngeal Neoplasms
21
Study Type: Observational
20
Head and Neck Neoplasms
20
Lip Neoplasms
19
Oropharyngeal Neoplasms
18
Phase: Phase 2
10
Neoplasms
9
Recurrence
7
Skin Neoplasms
6
Nasopharyngeal Carcinoma
6
Phase: Phase 1
5
Phase: Phase 2, Phase 3
5
Soft Tissue Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
83
2020-
5
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
88
Englisch
Haven't found what you're looking for?
Wird geladen...